United States Pharmaceutical 3PL Market Size

Statistics for the 2023 & 2024 United States Pharmaceutical 3PL market size, created by Mordor Intelligence™ Industry Reports. United States Pharmaceutical 3PL size report includes a market forecast to 2029 and historical overview. Get a sample of this industry size analysis as a free report PDF download.

Market Size of United States Pharmaceutical 3PL Industry

Single User License
Team License
Corporate License
Book before:
United States Pharmaceutical 3PL Market  Growth
share button
Study Period 2020 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2020 - 2022
CAGR > 4.00 %
Market Concentration Low

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

US Pharmaceutical 3PL Market Analysis

The US pharmaceutical third-party logistics market is expected to expand at a compound annual growth rate (CAGR) of more than 4% during the forecast period.

Due to COVID-19, the pharma supply chain was impacted by distribution challenges created by reduced transportation capacity. Disruptions at ports, quarantined crews, and labor shortages due to lockdowns are all contributing factors. COVID-19 caused the slowdown of the new pharmaceutical product development due to material shortages, disruptions in clinical trials, and backups in FDA approval.

However, the United States is the world's largest market for temperature-sensitive healthcare products such as biopharmaceuticals, vaccines, and clinical trial materials. The rising number of clinical trials employing various temperature-sensitive materials, such as blood samples, tissue samples, and some drugs, have catalyzed the growth of the market. There are many well-established pharmaceutical companies in the United States. The pharmaceutical industry of the United States alone accounts for almost half of the global pharmaceutical market.

Furthermore, the pharmaceutical 3PL industry is bound by strict rules and regulations. For instance, warehouses and shippers of pharmaceuticals in the United States must be registered with the Food and Drug Administration (FDA). There are no exceptions; even if they are planning a short-term or emergency relationship with a 3PL provider, one must make sure they are approved for storing and transporting pharmaceuticals. In addition, government regulations related to the distribution of pharmaceuticals are codified as part of the CGMPs (Current Good Manufacturing Practices), which is the best practice for the health and safety of consumers.

United States Pharmaceutical 3PL Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)